Blueprint Medicines Corporation (VWAVW) Stock Price & News

All values in USD	Dec 2025	Mar 2026	Jun 2026	Jun 2026
Revenue	-	-	286.34K	-
Cost of goods sold	-	-	171.76K	-
Cost of revenue	-	-	171.76K	-
Research and development expenses	-	315.08K	747.80K	271.53K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	-	6.13M	9.16M	5.08M
Operating expense	-	146.07K	18.26M	11.06M
Total operating expenses	-	146.07K	18.43M	11.06M
Operating income	-	-6.57M	-18.14M	-11.06M
Other non operating income	-	-226.68K	-2.22M	319.41K
EBT including unusual items	-	-6.94M	-25.93M	-12.91M
EBT excluding unusual items	-	-146.07K	-25.41M	-12.91M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-	-155.52K	-25.83M	-12.91M
Net profit margin	-	-	-9,022.02%	-
Earnings per share	-	-	-	-
Interest and investment income	-	988.00	185.79K	18.41K
Interest expense	-	-142.54K	-5.23M	-2.19M
Net interest expenses	-	-141.55K	-5.04M	-2.17M
Depreciation and amortization charges	-	118.90K	8.35M	5.70M
EBITDA	-	-6.45M	-9.79M	-5.35M
Gain or loss from assets sale	-	-	-	-

Ask anything